For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 142,674 | |||
| General and administrative | 29,567 | |||
| Total operating expenses | 172,241 | |||
| Loss from operations | -172,241 | |||
| Interest income | 6,031 | |||
| Interest expense | 2,004 | |||
| Other income, net | 358 | |||
| Net loss | -167,856 | |||
| Net unrealized gain (loss) on available-for-sale investments, net of tax | 25 | |||
| Net comprehensive loss | -167,831 | |||
| Basic EPS | -2.1 | |||
| Diluted EPS | -2.1 | |||
| Basic Average Shares | 6,000,000 | |||
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)